HETERO

HETERO is a factory.

Company Introduction:

Hetero Labs Limited is one of India's largest generic pharmaceutical companies and the world's largest producer of anti-retroviral drugs. Established in 1999, Hetero is a vertically integrated pharmaceutical organization with a focus on research and development, manufacturing, and marketing of high-quality active pharmaceutical ingredients (APIs), intermediates, and finished dosage formulations.

The company operates numerous state-of-the-art manufacturing facilities across India, which are approved by major global regulatory bodies such as the US FDA, EU GMP, UK MHRA, TGA Australia, and others. Hetero has a significant global presence, exporting its products to over 145 countries. Its extensive manufacturing capabilities span a wide range of therapeutic areas, including anti-retroviral, oncology, cardiovascular, neurology, nephrology, urology, diabetes, hepatology, and immunology. Hetero is recognized for its strong emphasis on innovation, affordability, and accessibility of medicines.

Hetero, an Indian pharmaceutical company, manufactures and sells a wide range of products across various therapeutic areas. Their product portfolio primarily includes:

Active Pharmaceutical Ingredients (APIs)

Finished Dosage Formulations in the following therapeutic categories:

Antiretrovirals (ARVs) for HIV/AIDS treatment

Oncology (Anti-cancer drugs)

Cardiovascular products

Diabetes management medications

Hepatology products (e.g., for Hepatitis C and B)

Neuroscience drugs

Pain Management and Anti-inflammatory drugs

Gastroenterology products

Dermatology products

Urology products

Respiratory drugs

Antibiotics and Anti-infectives

Biosimilars (biologic drugs)

During the COVID-19 pandemic, Hetero also notably produced and supplied drugs such as Remdesivir, Favipiravir, and Molnupiravir.